Search results

Filters
Close
ADDED DATE
Added date
TOPICS Please select
WATCH / LISTEN / READ TIME
ACC 22: 3-year Efficacy Outcomes from the SPYRAL HTN-ON MED Med Pilot Study
Author(s): Felix Mahfoud Added: 1 year ago
In this short late-breaking interview, Prof Felix Mahfoud (Saarland University Hospital, DE) discusses the 3-year efficacy outcomes of the SPYRAL HTN-ON MED Pilot Study (NCT02439775). The global clinical study, presented at ACC.22, tested the long-term effect of renal denervation (Symplicity Spyral™ multi-electrode renal denervation system, Medtronic Vascular) on blood pressure reduction in… View more

Prevention & Chronic Conditions

Intervention
Joachim Weil
Prof Joachim Weil is the Head of the Medical Department II - Cardiology and Angiology of the Sana Hospitals Lübeck. As a modern competence center, the Department of Cardiology and Angiology offers highly specialized medical services in addition to cardiological care. In addition, Sana Hospitals Lübeck cooperates closely with the University Hospital of Schleswig-Holstein. Professor Joachim Weil… View more
Thomas Weber
Job title: Associate Professor
Dr Thomas Weber is an Austrian cardiologist. He is Deputy Director of the Cardiology Department at the Klinikum Wels-Grieskirchen, in Wels, Austria.His clinical interests cover interventional cardiology, heart failure and hypertension while his scientific interests are pulsatile hemodynamics, arterial stiffness, vascular aging, 24-hour hemodynamics, heart failure, coronary artery disease,… View more
View from the Thoraxcenter: EuroPCR 23 Late-breaking Science Preview
Author(s): Nicolas M Van Mieghem , Joost Daemen Added: 1 year ago
Join Prof Nicolas Van Mieghem and Dr Joost Daemen, interventional experts from the Thoraxcenter at Erasmus MC in Rotterdam, as they provide a comprehensive preview of the late-breaking trials and studies that will be presented at EuroPCR 2023. In this dynamic episode, they offer valuable insights into the latest developments in interventional clinical and research science. Studies include:… View more

Intervention
Job title: MD
Dr Juan F. Iglesias is an interventional cardiologist at Geneva University Hospitals and Privat Docent at the University of Geneva, Switzerland. He obtained his medical degree at Lausanne University Hospitals in Switzerland and completed his general and interventional cardiology training at the same institution, at the London Chest Hospital (Barts Health NHS Trust, London, United Kingdom) and at… View more
Andrew SP Sharp
Research Area(s) / Expertise: Job title: Professor of Cardiology
Prof Andrew Sharp is a Professor of Cardiology at the University College Dublin and The Mater Misericordiae Hospital, Dublin, IE. Andrew qualified from Edinburgh Medical School in 1998. He was appointed as a Consultant Cardiologist at the Royal Devon and Exeter Hospital in 2011 and Honorary Associate Professor by the University of Exeter in 2018 before moving to the University Hospital of Wales… View more
New ESC Guidelines for the Management of Hypertension
Author(s): Rhian Touyz Added: 6 months ago
ESC Congress 2024 — Dr Rhian Touyz (McGill University Health Center, CA) joins us to discuss key highlights from the ESC 2024 guidelines for the management of elevated blood pressure and hypertension.The new guidelines introduce a new systolic blood pressure treatment target range of 120-129 mmHg, placing emphasis on an intensive target treatment as the first step in patient management - only… View more

Prevention & Chronic Conditions
View from the Thoraxcenter: TCT 23 Late-breaking Science Wrap Up
Author(s): Nicolas M Van Mieghem , Joost Daemen Added: 1 year ago
What are the top late-breaking trials from #TCT2023? TCT 2023 — Join interventional cardiologists, Prof Nicolas Van Mieghem and Dr Joost Daemen from the Thoraxcenter as they unpack the most impactful late-breaking clinical trials and science data from this year's Transcatheter Cardiovascular Therapeutics Conference. Dive into this practical and engaging discussion and learn more about the… View more

Intervention
View from the Thoraxcenter: What's Hot at ACC.24?
Author(s): Nicolas M Van Mieghem , Joost Daemen Added: 12 months ago
What’s hot at ACC.24?Join interventional experts, Prof Nicolas Van Mieghem and Dr Joost Daemen (Thoraxcenter, Erasmus MC, Rotterdam, NL) to learn more about this year’s key late-breaking and featured science trials that have the potential to shape practice and research.This preview episode of View from the Thoraxcenter offers a critical analysis of the most anticipated trials of ACC.24,… View more

Anticoagulation

Heart Failure
ACC.24 Late-breaking Science Preview
Added: 12 months ago
What’s hot at ACC.24?Join interventional experts, Prof Nicolas Van Mieghem and Dr Joost Daemen (Thoraxcenter, Erasmus MC, Rotterdam, NL) to learn more about this year’s key late-breaking and featured science trials that have the potential to shape practice and research.This preview episode of View from the Thoraxcenter offers a critical analysis of the most anticipated trials of ACC.24,… View more

Anticoagulation

Heart Failure